Home › Huntington's Disease › District of Columbia › Washington
Huntington's Disease clinical trials in Washington, DC
4 studies for Huntington's Disease are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pridopidine Phase 3 Study in Huntington's Disease
RecruitingPhase 3
- Georgetown University, Washington D.C.
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
RecruitingPhase 3
- Georgetown University, Washington D.C.
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
RecruitingObservational studyHealthy volunteers welcome
- Georgetown University, Washington D.C.
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
RecruitingObservational studyHealthy volunteers welcome
- Georgetown University, Washington D.C.
About Huntington's Disease
Huntington's disease (HD) is an inherited disease that causes nerve cells in the brain to waste away. It causes disability that gets worse over time.
More about Huntington's Disease on MedlinePlus
Huntington's Disease trials in other cities
- Houston, TX5 studies
- Durham, NC4 studies
- Boston, MA4 studies
- Nashville, TN4 studies
- New York City, NY4 studies
- Columbus, OH4 studies
- Baltimore, MD4 studies
- Denver, CO4 studies
- Rochester, NY4 studies
- Chicago, IL3 studies
- Birmingham, AL3 studies
- Cincinnati, OH3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.